Default company panoramic image

OncoHealth Corp

OncoHealth is developing novel diagnostics that can identify true disease for cancers associated with HPV, initially cervical cancer.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location San Jose, CA, USA
  • Currency USD
  • Website

Company Summary

OncoHealth Corporation is developing novel proprietary diagnostic and screening tests for cervical cancer and other cancers associated with human papillomavirus (HPV). The company’s tests can differentiate true disease from benign HPV infection and help guide effective treatment decisions. This valuable information cannot be obtained from existing molecular diagnostic tests or the Pap test.


  • Default avatar
    Winnie H. Wan
    Chairman & CEO

    Dr. Wan has extensive experience in launching and building life science companies and has successfully commercialized disruptive technologies that resulted in successful exits. These technologies include the analytical systems for drug development at ForteBio, Inc (acquired by Pall Corp. in Dec, 2011)., the anatomical pathology systems for cancer diagnosis at Becton Dickinson, the cell analysis systems at Guava Technologies, Inc (acquired by Mill